TIDMCBX

RNS Number : 8244N

Cellular Goods PLC

04 October 2021

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

Press release

4 October 2021

Cellular Goods PLC

("Cellular Goods" or "the Company")

Director dealings & TR1 notification

Cellular Goods (LSE: CBX), a UK-based provider of premium consumer products formulated with lab-made cannabinoids, announces that Alexis Abraham, chief executive, purchased two million ordinary shares in the Company at 7.75 pence each on 1 October 2021.

The acquisition has increased his total holding to 20.5 million shares, representing 4.1% of the issued capital in the Company, as per the notification below.

TR-1: Standard form for notification of major holdings

 
 NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and 
  to the FCA in Microsoft Word format if possible) (i) 
 
 1a. Identity of the issuer or the                            Cellular Goods plc 
  underlying issuer of existing shares                         LEI: 213800IXPX4Z2MKX2U28 
  to which voting rights are attached 
  (ii) : 
                                                             -------------------------------------------- 
 1b. Please indicate if the issuer is a non-UK issuer (please mark with 
  an "X" if appropriate) 
 
 2. Reason for the notification (please mark the appropriate box or boxes 
  with an "X") 
 An acquisition or disposal of voting rights                                                           X 
                                                                                                     ---- 
 An acquisition or disposal of financial instruments 
                                                                                                     ---- 
 An event changing the breakdown of voting rights 
                                                                                                     ---- 
 Other (please specify)(iii) : 
                                                                                                     ---- 
 3. Details of person subject to the notification obligation (iv) 
 Name                                                         Alexis Abraham, CEO 
 City and country of registered office 
  (if applicable) 
 4. Full name of shareholder(s) (if different from 3.) (v) 
 Name 
                                                             -------------------------------------------- 
 City and country of registered office 
  (if applicable) 
                                                             -------------------------------------------- 
 5. Date on which the threshold was                           1 Oct. 2021 
  crossed or reached (vi) : 
                                                             -------------------------------------------- 
 6. Date on which issuer notified (DD/MM/YYYY):               1 Oct. 2021 
                                                             -------------------------------------------- 
 7. Total positions of person(s) subject to the notification obligation 
                              % of voting       % of voting rights    Total of both   Total number 
                            rights attached      through financial     in % (8.A +     of voting rights 
                            to shares (total        instruments            8.B)        of issuer (vii) 
                                of 8. A)           (total of 8.B 
                                                    1 + 8.B 2) 
                          ------------------  ---------------------  --------------  -------------------- 
 Resulting situation 
  on the date 
  on which threshold 
  was crossed 
  or reached               4.1%                  n/a                                  504,750,000 
                          ------------------  ---------------------  --------------  -------------------- 
 Position of 
  previous notification 
  (if 
  applicable)              3.7%                  n/a                   3.7%           504,750,000 
                          ------------------  ---------------------  --------------  -------------------- 
 
 
 
 8. Notified details of the resulting situation on the date on which 
  the threshold was crossed or reached (viii) 
 A: Voting rights attached to shares 
 Class/type of      Number of voting rights                             % of voting rights 
  shares             (ix) 
  ISIN code (if 
  possible) 
                           Direct                   Indirect                     Direct                  Indirect 
                     (Art 9 of Directive       (Art 10 of Directive        (Art 9 of Directive     (Art 10 of Directive 
                         2004/109/EC)              2004/109/EC)           2004/109/EC) (DTR5.1)        2004/109/EC) 
                           (DTR5.1)                 (DTR5.2.1)                                          (DTR5.2.1) 
                                           -------------------------- 
 GB00BK964W87       20,500,000               n/a                        4.1%                        n/a 
                   ----------------------  --------------------------  -------------------------  --------------------- 
 
 
 SUBTOTAL 8. A                         20,500,000                                            4.1% 
                   --------------------------------------------------  ------------------------------------------------ 
 
 B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC 
  (DTR5.3.1.1 (a)) 
 Type of            Expiration   Exercise/                       Number of voting                  % of voting 
  financial          date         Conversion Period               rights that may                   rights 
  instrument         (x)          (xi)                            be acquired if 
                                                                  the instrument 
                                                                  is 
                                                                  exercised/converted. 
                   -----------  ------------------------------  --------------------------------  --------------------- 
 
 
 
                                 SUBTOTAL 8. B 1                  n/a                               n/a 
                                ------------------------------  --------------------------------  --------------------- 
 
 B 2: Financial Instruments with similar economic effect according to 
  Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) 
 Type of       Expiration        Exercise/             Physical or           Number of             % of voting 
  financial     date (x)          Conversion            cash                  voting rights         rights 
  instrument                      Period (xi)           settlement 
                                                        (xii) 
              ----------------  --------------------  --------------------  -------------------- 
 
 
 
                                                       SUBTOTAL 8.B.2         n/a                    n/a 
                                                      --------------------  -------------------- 
 
 
 
 
 9. Information in relation to the person subject to the notification 
  obligation (please mark the 
  applicable box with an "X") 
 Person subject to the notification obligation is not controlled                        X 
  by any natural person or legal entity and does not control any other 
  undertaking(s) holding directly or indirectly an interest in the 
  (underlying) issuer (xiii) 
 Full chain of controlled undertakings through which the voting rights 
  and/or the 
  financial instruments are effectively held starting with the ultimate 
  controlling natural person or legal entity (xiv) (please add additional 
  rows as necessary) 
    Name (xv)        % of voting rights      % of voting rights       Total of both if 
                       if it equals or        through financial        it equals or is 
                      is higher than the      instruments if it        higher than the 
                     notifiable threshold    equals or is higher     notifiable threshold 
                                             than the notifiable 
                                                  threshold 
                   ----------------------  ---------------------  ------------------------ 
 
 
 
 
 
 
 10. In case of proxy voting, please identify: 
 Name of the proxy holder 
                                           ----------------------------------------------- 
 The number and % of voting rights 
  held 
                                           ----------------------------------------------- 
 The date until which the voting rights 
  will be held 
                                           ----------------------------------------------- 
 
 11. Additional information (xvi) 
 
 
 
 
 Place of completion   London, UK 
 Date of completion    2 Oct. 2021 
                      ------------ 
 

For further information please contact:

 
 Cellular Goods 
 Alexis Abraham                        +44 207 031 6871 
  Chief Executive 
  Neil Thapar 
  Investor Relations                    +44 787 645 5323 
                                      ------------------- 
 Tennyson Securities 
                                      ------------------- 
 Corporate Broker 
  Peter Krens                            +44 207 186 9030 
                                      ------------------- 
 Novum Securities 
                                      ------------------- 
 Corporate Broker 
  Colin Rowbury 
  Jon Belliss                            +44 207 399 9427 
                                      ------------------- 
 Tancredi Intelligent Communication 
                                      ------------------- 
 Media Relations 
  Helen Humphrey 
  Edward Daly                            +44 744 922 6720 
  Salamander Davoudi                     +44 786 143 0057 
  cellulargoods@tancredigroup.com        +44 795 754 9906 
                                      ------------------- 
 

About Cellular Goods PLC

Cellular Goods is a U.K.-based provider of premium consumer products incorporating lab-made cannabinoids. It was established in August 2018 to develop and market efficacy-led and research-backed cannabinoid products. The initial focus is on three categories: premium CBG skincare, CBD ingestibles, and CBD topical athletic recovery formulas. The first products will launch December 2021 and be available direct to consumers through the Company's website.

www.cellulargoods.co

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLFLFVEISLVIIL

(END) Dow Jones Newswires

October 04, 2021 02:00 ET (06:00 GMT)

Cellular Goods (LSE:CBX)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas Cellular Goods.
Cellular Goods (LSE:CBX)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas Cellular Goods.